Treatment of Neuroendocrine Tumor Liver Metastases

Por Lewis, Mark A., Hobday, Timothy J.
Publicado em 2012

Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy

Por Walia, Tamana, Quevedo, J Fernando, Hobday, Timothy J, Croghan, Gary, Jatoi, Aminah
Publicado em 2008

Risk Factors for Pancreatic Neuroendocrine Tumors (PNETs): A Clinic-Based Case-Control study

Por Halfdanarson, Thorvardur R., Bamlet, William R., McWilliams, Robert R, Hobday, Timothy J., Burch, Patrick A., Rabe, Kari G., Petersen, Gloria M.
Publicado no Pancreas (2014)

Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144

Por Dy, Grace K., Hobday, Timothy J., Nelson, Garth, Windschitl, Harold E., O’Connell, Michael J., Alberts, Steven R., Goldberg, Richard M., Nikcevich, Daniel A., Sargent, Daniel J.
Publicado em 2009

Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors

Por Hobday, Timothy J., Qin, Rui, Reidy-Lagunes, Diane, Moore, Malcolm J., Strosberg, Jonathan, Kaubisch, Andreas, Shah, Manisha, Kindler, Hedy Lee, Lenz, Heinz-Josef, Chen, Helen, Erlichman, Charles
Publicado no J Clin Oncol (2015)

Breast Medical Oncologists' Use of Standard Prognostic Factors to Predict a 21-Gene Recurrence Score

Por Kamal, Arif H., Loprinzi, Charles L., Reynolds, Carol, Dueck, Amylou C., Geiger, Xochiquetzal J., Ingle, James N., Carlson, Robert W., Hobday, Timothy J., Winer, Eric P., Goetz, Matthew P.
Publicado em 2011

North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane

Por Sideras, Kostandinos, Dueck, Amylou C., Hobday, Timothy J., Rowland, Kendrith M., Allred, Jacob B., Northfelt, Donald W., Lingle, Wilma L., Behrens, Robert J., Fitch, Tom R., Nikcevich, Daniel A., Perez, Edith A.
Publicado em 2012

Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting

Por Kulke, Matthew H., Siu, Lillian L., Tepper, Joel E., Fisher, George, Jaffe, Deborah, Haller, Daniel G., Ellis, Lee M., Benedetti, Jacqueline K., Bergsland, Emily K., Hobday, Timothy J., Van Cutsem, Eric, Pingpank, James, Oberg, Kjell, Cohen, Steven J., Posner, Mitchell C., Yao, James C.
Publicado em 2011

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

Por Yao, James C., Shah, Manisha H., Ito, Tetsuhide, Bohas, Catherine Lombard, Wolin, Edward M., Van Cutsem, Eric, Hobday, Timothy J., Okusaka, Takuji, Capdevila, Jaume, de Vries, Elisabeth G.E., Tomassetti, Paola, Pavel, Marianne E., Hoosen, Sakina, Haas, Tomas, Lincy, Jeremie, Lebwohl, David, Öberg, Kjell
Publicado em 2011

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

Por Yao, James C., Lombard-Bohas, Catherine, Baudin, Eric, Kvols, Larry K., Rougier, Philippe, Ruszniewski, Philippe, Hoosen, Sakina, St. Peter, Jessica, Haas, Tomas, Lebwohl, David, Van Cutsem, Eric, Kulke, Matthew H., Hobday, Timothy J., O'Dorisio, Thomas M., Shah, Manisha H., Cadiot, Guillaume, Luppi, Gabriele, Posey, James A., Wiedenmann, Bertram
Publicado no J Clin Oncol (2010)

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Clinical Outcomes and Predi...

Por Lin, Nancy U., Guo, Hao, Yap, Jeffrey T., Mayer, Ingrid A., Falkson, Carla I., Hobday, Timothy J., Dees, E. Claire, Richardson, Andrea L., Nanda, Rita, Rimawi, Mothaffar F., Ryabin, Nicole, Najita, Julie S., Barry, William T., Arteaga, Carlos L., Wolff, Antonio C., Krop, Ian E., Winer, Eric P., Van den Abbeele, Annick D.
Publicado no J Clin Oncol (2015)

Genetic Predictors of Taxane-induced Neurotoxicity in a SWOG Phase III Intergroup Adjuvant Breast Cancer Treatment Trial (S0221)

Por Sucheston, Lara E., Zhao, Hua, Yao, Song, Zirpoli, Gary, Liu, Song, Barlow, William E., Budd, G. Thomas, Hershman, Dawn L., Davis, Warren, Ciupak, Gregory L., Stewart, James A., Isaacs, Claudine, Hobday, Timothy J., Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Livingston, Robert B., Albain, Kathy S., Hayes, Daniel F., Ambrosone, Christine B.
Publicado em 2011

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

Por Carey, Lisa A., Rugo, Hope S., Marcom, P. Kelly, Mayer, Erica L., Esteva, Francisco J., Ma, Cynthia X., Liu, Minetta C., Storniolo, Anna Maria, Rimawi, Mothaffar F., Forero-Torres, Andres, Wolff, Antonio C., Hobday, Timothy J., Ivanova, Anastasia, Chiu, Wing-Keung, Ferraro, Madlyn, Burrows, Emily, Bernard, Philip S., Hoadley, Katherine A., Perou, Charles M., Winer, Eric P.
Publicado em 2012

Effect of Metformin vs Placebo on Weight and Metabolic Factors in NCIC CTG MA.32

Por Goodwin, Pamela J., Parulekar, Wendy R., Gelmon, Karen A., Shepherd, Lois E., Ligibel, Jennifer A., Hershman, Dawn L., Rastogi, Priya, Mayer, Ingrid A., Hobday, Timothy J., Lemieux, Julie, Thompson, Alastair M., Pritchard, Kathleen I., Whelan, Timothy J., Mukherjee, Som D., Chalchal, Haji I., Oja, Conrad D., Tonkin, Katia S., Bernstein, Vanessa, Chen, Bingshu E., Stambolic, Vuk
Publicado no J Natl Cancer Inst (2015)

Germline genetic variants in ABCB1, ABCC1, and ALDH1A1 and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer

Por Yao, Song, Sucheston, Lara E., Zhao, Hua, Barlow, William E., Zirpoli, Gary, Liu, Song, Moore, Halle C.F., Budd, G. Thomas, Hershman, Dawn L., Davis, Warren, Ciupak, Gregory L., Stewart, James A., Isaacs, Claudine, Hobday, Timothy J., Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Livingston, Robert B., Albain, Kathy S., Hayes, Daniel F., Ambrosone, Christine B.
Publicado em 2013

SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer

Por Budd, George T., Barlow, William E., Moore, Halle C.F., Hobday, Timothy J., Stewart, James A., Isaacs, Claudine, Salim, Muhammad, Cho, Jonathan K., Rinn, Kristine J., Albain, Kathy S., Chew, Helen K., Burton, Gary V., Moore, Timothy D., Srkalovic, Gordan, McGregor, Bradley A., Flaherty, Lawrence E., Livingston, Robert B., Lew, Danika L., Gralow, Julie R., Hortobagyi, Gabriel N.
Publicado no J Clin Oncol (2015)